http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1471892-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d32a49211015b18ecef5a3a5195bf06e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfae81468523c4a7e635145a1bfe2359
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
filingDate 2002-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d93118d28807d6e915e9cdd0f7e0a985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16e8a90a00d673fda65f80db2cc00dbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ec537038a73e072ffce1c2a5e5d4f4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbfc2d7215c3596931a091185413974d
publicationDate 2004-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1471892-A2
titleOfInvention Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
abstract This invention provides the use of a silicone-based transdermal therapeutic system having an area of 10 to 40 cm<2> and containing 0.1 to 3.15 mg / cm<2> of rotigotine as active ingredient, for the preparation of an anti-Parkinson medicament which induces a mean plasma concentration of rotigotine in the range of 0.4 to 2 ng/ml 24 h after administration.
priorityDate 2001-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127529620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54481357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128972812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226433869
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226428258
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9953598
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405769
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395454
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411642
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399716
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54680660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128375599
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28864
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412729
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228694818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129721219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57537
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129497604

Total number of triples: 53.